Autoantibodies and Peripheral Arterial Occlusive Disease;Humorale Vaskulitisdiagnostik bei peripherer arteirieller Verschlusskrankheit

Herz

Volumn 29, Issue 1, 2004, Pages 26-31

  Kroeger, Knut ^a   Kreuzfelder, Ernst ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Autoantibodies; Collagen disease; Peripheral arterial occlusive disease; Vasulitis

Indexed keywords

ANTIBODY; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; C REACTIVE PROTEIN; DNA ANTIBODY; GLYCOPROTEIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY; PROTEIN JO 1; PROTEIN SCL 70; RIBONUCLEOPROTEIN; RO ANTIBODY; SMOOTH MUSCLE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CAUSE OF DEATH; COLLAGEN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; IMMUNOFLUORESCENCE; ISCHEMIC HEART DISEASE; LIMB AMPUTATION; MAJOR CLINICAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROSPECTIVE STUDY; VASCULITIS; ANGIOGRAPHY; ARTERITIS; BLOOD; CONNECTIVE TISSUE DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; DIFFERENTIAL DIAGNOSIS; FEMALE; IMMUNOLOGY; ISCHEMIA; LEG; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR; VASCULARIZATION;

ADULT; AGED; ANGIOGRAPHY; ANTIBODIES, ANTINUCLEAR; ARTERIAL OCCLUSIVE DISEASES; ARTERITIS; AUTOANTIBODIES; C-REACTIVE PROTEIN; CONNECTIVE TISSUE DISEASES; CORONARY ARTERIOSCLEROSIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; RISK FACTORS;

EID: 1442352796     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-004-2548-6     Document Type: Article

References (25)

1. Afek A, George J, Shoenfeld Y, Gilburd B, Levy Y, Shaish A, Keren P, Janackovic Z, Goldberg I, Kopolovic J, Harats D. Enhancement atherosclerosis in apoE deficient mice by immunization with beta2-glycoprotein I. Pathobiology 1999;67:19-25.
2. Arbuckle MR, McCLain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
3. Bili A, Moss AJ, Francis CW, Zareba W, Watelet LF, Sanz I. Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic factors, and recurrent coronary events investigators. Circulation 2000 12;102:1258-63.
4. Cristina T, Brusca I, Fazio M, Sarullo FM.The beta2-glycoprotein I-dependent anticardiolipin antibodies: their importance as risk factors for ischemic stroke and myocardial infarction. Haematologica 2002;87:Suppl:96.
5. Farhey Y, Hess EV. Accelerated atherosclerosis and coronary disease in SLE. Lupus 1997;6:572-7.
6. George J, Afek A, Gilburd B, Blank M, Levy Y, Aron-Maor A, Levkovitz H, Shaish A, Goldberg I, Kopolovic J, Harats D, Shoenfeld Y. Induction of early atherosclerosis in LDL receptor-deficient mice immunized with beta2-glycoprotein I. Circulation 1998;15:1108-15.
7. George J, Harats D, Gilburd B, Afek A, Shaish A, Kopolovic J, Shoenfeld Y. Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 2000;102:1822-7.
8. George J, Harats D, Gilburd B, Shoenfeld Y. Emerging cross-regulatory roles of immunity and autoimmunity in atherosclerosis. Immunol Res 1996;15:315-22.
9. George J, Harats D, Gilburd B, Afek A, Levy Y, Schneiderman J, Barshack I, Kopolovic J, Shoenfeld Y. Immunolocalization of beta2-glykoprotein I to human atherosclerotic plaques: potential implications for lesion progression. Circulation 1999;99: 2227-30.
10. Grainger DJ, Bethell HWL. High titres of serum antinuclear antibodies, mostly directed against nucleolar antigens, are associated with the presence of coronary atherosclerosis. Ann Rheum Dis 2002;61:110-4.
11. Hunder GG, Arend WP, Bloch DA, Calabrese JH, Fauci AS, Fries JF, Leavitt RY, Lie JT, Lightfoot jr, Masi AT, McShane DJ, Michel BA, Mills JA, Stevens MB, Wallace SL, Zvaifler NU. The American College of Rheumatology 1990 criteria for classification of vasculitis. Arthritis Rheum 1990;33:1065-7.
12. Jennette CJ, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffmann GS, Hunder GG, Kallenberg SGM, McCluskey RT, Sinico RA, Ree AJ, van Es LA, Waldher R, Wiik A. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
13. Jennette JC, Falk R: Small-vessel vasculitis. N Engl J Med 1997; 337;1512-23.
14. Kandia DA, Krilis SA. Beta2-glyoprotein I. Lupus 1994;3:207-12.
15. Limaye V, Beltrame J, Cook R, Gillis D, Pile K. Evaluation of antibodies to beta2-glycoprotein-I in the causation of coronary atherosclerosis as part of the antiphospholipid syndrome. Aust NZJ Med 1999;29:789-93.
16. Moulias R, Praust J, Wang A, Congy F, Marescot MR, Deville Chabrolle A, et al. Age related increase in autoanibodies. Lancet 1984;1128-9.
17. Nakken B, Davis KE, Pan ZJ, Bachamnn M, Farris AD. T-Helper cell tolerance to ubiquitous nuclear antigens. Scand J Immunol 2033;58:478-92.
18. Schwarz-Eywill M, Rinaldi N, Barth T, Nusslein HG. Rare manifestation of large vessel vasculitis in systemic lupus erythematosus. Z Rheumatol 2000;59:330-3.
19. Wheatley MJ, Hennein HA, Greenfield U. Lower extremity arterial disease in systemic lupus erythematosus. Arch Surg 1991;126: 109-10.
20. Sherer Y, Shoenfeld Y. Atherosclerosis. Ann Rheum Dis 2002; 61:97-9.
21. Sherer Y, Shoenfeld Y. Antiphoslipid sndrome, antiphospholipid antibodies and athersclerosis. Curr Atheroscler Rep 2001;3:328-33.
22. Sherer Y, Tenenbaum A, Praprotnik S, Shemesh J, Blank M, Fisman EZ, Harats D, George J, Levy Y, Peter JB, Motro M, Shoenfeld Y. Coronary artery diseases but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotien-1 and oxidized LDL antibodies. Cardiology 2001;95:20-4.
23. Sherer Y, Tenenbaum A, Praprotnik S, Shemesh J, Blank M, Fisman EZ, Motro, M, Shoenfeld Y. Autoantibodies to cardiolipin and beta-2-glycoprotein-1 in coronary artery disease patients with and without hypertension. Cardiology 2002;97:2-5.
24. Veale DJ, Collidge TA, Belch JJ. Increased prevalence of symptomatic macrovascular disease in systemic sclerosis. Ann Rheum Dis 1995;54:853-5.
25. Wick G, Schett G, Amberger A, Setitz CS, Michaelis D, Metzler B. Is atherosclerosis an immunologically mediated disease? Immunol Today 1995;16:27-33.